Rotterdam, The Netherlands, June 21 (Bernama-GLOBE NEWSWIRE) —
Summary:
- Centrient Pharmaceuticals has started production at its newly built statins API manufacturing unit in Toansa, India.
- With this expansion the company is doubling its production capacity of Atorvastatin and Rosuvastatin, meeting the increased demand for its high-quality uniquely produced statins.